Abstract
Background. Parainfluenza virus (PIV) is a leading cause of lower respiratory tract infections. Although there are several distinct PIV serotypes, few studies have compared the clinical characteristics and severity of infection among the individual PIV serotypes and between PIV and other pathogens in patients with community-acquired pneumonia. Methods. We conducted active population-based surveillance for radiographically confirmed community-acquired pneumonia hospitalizations among children and adults in 8 US hospitals with systematic collection of clinical data and respiratory, blood, and serological specimens for pathogen detection. We compared clinical features of PIV-associated pneumonia among individual serotypes 1, 2, and 3 and among all PIV infections with other viral, atypical, and bacterial pneumonias. We also compared in-hospital disease severity among groups employing an ordinal scale (mild, moderate, severe) using multivariable proportional odds regression. Results. PIV was more commonly detected in children (155/2354; 6.6%) than in adults (66/2297; 2.9%) (P < .001). Other pathogens were commonly co-detected among PIV cases (110/221; 50%). Clinical features of PIV-1, PIV-2, and PIV-3 infections were similar to one another in both children and adults with pneumonia. In multivariable analysis, children with PIV-associated pneumonia exhibited similar severity to children with other nonbacterial pneumonia, whereas children with bacterial pneumonia exhibited increased severity (odds ratio, 8.42; 95% confidence interval, 1.88–37.80). In adults, PIV-associated pneumonia exhibited similar severity to other pneumonia pathogens. Conclusions. Clinical features did not distinguish among infection with individual PIV serotypes in patients hospitalized with community-acquired pneumonia. However, in children, PIV pneumonia was less severe than bacterial pneumonia.
| Original language | English (US) |
|---|---|
| Pages (from-to) | E4433-E4443 |
| Journal | Clinical Infectious Diseases |
| Volume | 73 |
| Issue number | 11 |
| DOIs | |
| State | Published - Dec 1 2021 |
Funding
The EPIC study was supported by the Influenza Division in the National Center for Immunizations and Respiratory Diseases at the Centers for Disease Control and Prevention through cooperative agreements with each study site and was based on a competitive research funding opportunity. L. M. H. is supported by the National Institutes of Health under award number 1K23AI141621. This work was performed by L. M. H. as a Young Investigator Award recipient of the IDSA Education and Research Foundation (ERF) sponsored by Pfizer. C. G. G. was supported in part by the National Institutes of Health (grant number NIAID K24AI148459).
Keywords
- Community-acquired pneumonia
- Parainfluenza virus
- Viral pneumonia
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases